Protokoly_diagnostiki_i_lechenia_zabolevany
.pdf: 15-138
"$ &: -" :
& ! : ' %(') ), " $ ;; & ( ."." $).
' & & : 14
(: O36.5 + " , $#
# |
|
|
P05 ) " & |
|
|
P05.0 |
"6 " |
|
P05.1 |
6 |
|
P05.2 |
+ " & " " |
|
) : ' % - 3
& H)- .
$ :
1. |
: ; . |
2. |
: " ; " . |
* :
1.! &-3 " :
-&-3 " ;
- & # ;
-& ;
-« " » ( , &, )
2.:
-;
- " " ; - & ;
- , [ # .
3.! $# :
- " & ; - % ;
-" ;
-;
-;
-%[ ;
- % , " # ;
4.B :
- : , , |
, ; |
|
- & : , [ , |
, ; |
|
- |
: , . |
|
5. |
? : |
|
- % ') ( & 25%); - % ; - , "[ ;
-( 16 35 ).
6.% :
-3 ;
-" 2 3 ;
-&;
- ( % ).
-;
-" '!@6 ( 3 ).
" :
" :
- " & " ; -& V " % ;
-& & " & ;
- & |
; |
|
-" ') % % ; |
||
- 3 & " ') |
||
- & . |
||
|
5 |
: |
- |
" ; |
|
- |
, Rh-; |
|
-" ; |
||
- HbsAg; |
|
|
- 'BL; |
|
|
-H)B ; |
|
|
- |
" ; |
|
-& ?@. |
|
|
|
: |
|
1.&
|
& 12 & |
|
( " & 7 ) & H)- |
|
; |
2.% % ;
3.'!@6 & , " ( 3 ).
+ % & % & " '!@6 $# 1$ % 20-36 . + '!@6 3-4 % & H)B, # % & " .
" & :
1.@ " ;
2. |
H & |
') $# |
: |
|
|||
|
- % 4 , III % 2-3 ; |
|
|
||||
|
- |
$ H)B; |
|
|
|
||
|
- V " % ( – |
||||||
|
, |
|
|
& |
1-2 |
$ |
|
|
– " # ); |
|
|
|
|
|
|
|
- & |
; |
|
|
|
||
|
-" |
& |
|
|
|
|
|
3. |
@ " |
"- - |
|
|
|
||
$# : |
|
|
|
|
|
|
|
- " ; - " ; - ;
- " % " .
4.! ;
5.; " &;
6.+ ;
" & & : |
|
+ : |
|
1. |
J " $# , # ') ; |
2. |
@ " & ; |
3. |
! " . |
4. |
6 " . |
@ " |
|
|
% |
|
|
|||
. + , " " |
% |
|||||||
|
|
& |
" |
|
. |
|
|
|
" |
|
|
|
" |
, |
" |
||
37 &, " |
. ' " |
|||||||
" , "" 3 " , " " , . "$ ') 34 &" " <_. B %" "( ; ) <_ 1-26 . &; % ; /<_ @ . @ "
|
|
|
" |
|
|
|
|
|
; |
( & & L!!), <_ ( % 4) |
|||||||||
|
& |
" . ' 36 |
|||||||
& |
" |
- |
|
||||||
" . |
|
|
|
|
|
|
|||
& |
|
& |
|||||||
|
. |
|
|
|
|
|
|
||
: |
|
|
|
|
|
|
|
|
|
- |
|
; |
|
|
|
|
|
||
-" " " ;
-.
" & : " & & :
,- ! :
- ; - " ; -& ; -& ; <_;
-.
/, & :
1.National Guideline Clearinghouse: Intrauterine Growth Restriction.- www.guideline.gov
2.National Guideline Clearinghouse: ACR Appropriateness Criteria for Growth Disturbances: Risk of Intrauterine Growth Restriction.- www.guideline.gov
3.Royal College of Obstetricians and Gynecologists. Setting Standart to Improve Women’s Health
– The Investigation and Managment of the Small-For-Gestational-Age Fetus.- Guideline #31, 2002, p.16
4.National Collaborating Center for Women’s and Children’s Health. Antenatal Care: Rutine Care for the Healthy Pregnant Women. Clinical Guideline, 2003, p.286
5.Institute for Clinical Systems Improvement. Health Care Guideline. Rutine Prenatal Care, 2005, p.80
6.' % . – O &.- 2001.- .21
* – , # (% % )
|
) |
|
|
: 14-132 |
|
|
|
"$ &: – " |
|
|
|
: |
|
|
|
& ! : J " , &$, |
, |
||
|
, . |
||
' & & : 10-14 |
|
|
|
(: |
O12 ' &$ |
|
|
|
12.0 ' &$ |
|
|
|
O12.1 ' &$ |
|
|
|
O12.2 ' &$ |
|
|
) : ) – % , 12 " & % 2,2 $.
$ :
* : 80% " |
( 300 |
||||
/ ) & |
" . |
||||
" : |
|
|
|
||
" |
|
: % |
; |
||
3 |
. |
|
|
|
|
|
5 |
|
: |
||
" ; |
|
||||
|
, Rh-; |
|
|
|
|
" ; |
|
|
|||
# " |
|
|
|
||
|
|
: , % " ; |
|||
; 0,3 / ; & & .
" & :
1.,
3." $ $
5."
6."
7." & ,
8.&
9. H)B 20-22, 30-34
10.% ,
11.&
12." "
" & & :
1.HbsAg
2.? HCV
+ :
1.J "-& % ;
2.' ; 3.@ .
+ & & & ( &$ V % , $
" % ), & " & % ( & $V % ). " .
' & %. ' $#% & # & $, " " ,$# 300 / , " " &.
" & :
1. V 20 1 ,
" & & :,- ! : - " ; - & ;
-.
/, & :
1.National Guideline Clearinghouse: www.guideline.gov
National High Blood Pressure Education Program: Working Group report on high blood pressure in pregnancy;
Preeclampsia Community Guideline.
2.Royal College of Obstetricians and Gynecologists. Setting Standart to Improve Women’s Health
Managment of Eclampsia
Pre-eclampsia – Study Group Recommendations
3.Scottish Obstetric Guidelines and Audit Project. Managment of Non-proteinuric Hypertension in Pregnancy
4.Institute for Clinical Systems Improvement. Health Care Guideline. Rutine Prenatal Care, 2005, p.80
5.National Collaborating Center for Women’s and Children’s Health. Antenatal Care: Rutine Care for the Healthy Pregnant Women. Clinical Guideline, 2003, p.286
6.? & . " . O &, 1999, .34
* – , # (% % )
": 14-128
"$ &: -" : &
& ! : ; " V , %, " " " , " " " " , & " .
' & & : 7
(: 72.2 " "
) : ( " ) |
" ( ) – " |
V 500 , |
24 " 6 & . |
" $ & ( ), ( , # ),, , 3 ", 3 & " .
$ : :
1.H - V 500-1000 ;
2.6 – V 1000 .
* :
_ " " :% ;
% ;
6 &;
3 ;
" ;
" ;
% ;
|
|
" ; |
|
) % " |
; |
!-& 3 ;
" ( # , -
3 , 3 );
@ & & 12 " ;
' % 4000 ;
.
? & &
6
! &
6
6 %
@'!-
" : 3
|
|
: |
" ( % – " ); |
||
+ " |
" " ( , |
|
|
( , # ), , |
|
, 3 & " ); ! " ( & " ?@ % 80 . . .,
, & % , , )
" & :
Rh- & ;
# ( : , , );
( , , ,
, );
' ;
H & $ ( , , $ & , " );
L " # , & & ;
" & & :
" & "$:
-3 ;
- " _; - & . -HbsAg;
-A HCV.
+ : " "" % V$# % , , " " . ! " &, " " & % & ,$ & .
+ % " :
1.H " – " V 500-1000 ":
" ( $ 14-16 G, " );
" ;
& $# ;
B ( ) V $# % .
B % % .
2.6 " – " V 1000 ":
" ( $ 14-16 G);
& # ;
" % " &$ 8 / .;
; ;
& & .
6 7 , ?@, L!!, SpO2;
! " B'J ( ).
! " : 1. < V $# %